AbbVie’s Post

The world of clinical trials is complex and rigorous, with high stakes attached to every decision and action. The introduction of Interim Locking and its subsequent enhancements can have profound implications, not just for the companies involved but for patients worldwide who depend on the outcomes of these trials.

Only 2 days left! Register now for our next Life Sciences - In Focus webinar to gain expert insights into how we can produce diverse and representative data. https://lnkd.in/ejVquDWQ #LifeSciences #Innovation

🔬 Today's third panel looked at one of the year's key investment themes. 'The Future of Medicine' | Chaired by Dr. Patrick Pfeffer, Panelists: Matt McGrath, Brian Firth, Sean McClain & Dr. James Helliwell. The panelists discussed the latest innovations in healthcare, from drug delivery and rapid diagnostics to artificial intelligence powering drug creation and next-gen imaging. The audience questions centered around investable themes and diversifying across types and stages of development. "The latest technological advancements will have a profound impact on health and medicine, what does that mean for family offices?". Explore today's agenda: www.gpfo.com/today IDG | #familyoffices #investmentthemes #futureofmedicine

Empower your clinical studies with the power of our global network. Renowned scientists from around the world, each bringing significant expertise and experience, are ready to help you elevate your research to new heights. Discover how: https://loom.ly/so__QBI #VoiantClinical #AcceleratingInsights

Have you signed up for Oracle Life Sciences' November 28 Innovation Series webinar? Register now to hear about the impact of trial design on participants and learn why a patient-centric approach can lead to more successful clinical trials. https://lnkd.in/eTxybyED

Progress in transformative therapy and medical breakthroughs are unfolding at an unprecedented rate in human history.  Despite the progress in transformative therapies, navigating the clinical study approval process remains a steep challenge, leading to an increasing demand for innovation in trial design. In our whitepaper, Seth Halvorson shares insights on navigating complexity and enhancing enrollment in transformative therapies.  🔍Read now at https://lnkd.in/gwGQ8vm8 #WCG #clinicalresearch #clinicaltrial #innovation  

How do you go from scientific discovery to commercial innovation? Our partners at Rosalind Franklin University of Medicine and Science will be answering that question, and helping you protect your ideas at this upcoming event on April 17th... #science #medicine #research #innovation #lifescience https://hubs.li/Q02sty5P0

Diversity in clinical trials is vital for scientific progress and drug discovery. While age diversity has often been overlooked, it's a crucial factor. Regulators acknowledge this need, but challenges persist. To address this, we must: 1. Simplify technology for older participants. 2. Provide humanized support. 3. Ensure clarity and transparency in the trial process. These steps, when enacted, have the potential to enhance clinical research. #ClinicalTrials #Age #Diversity #Innovation

From new guidance related to single trial approvals to a call for reforms in European medtech regulations, here’s the latest in life sciences.

From new guidance related to single trial approvals to a call for reforms in European medtech regulations, here’s the latest in life sciences.